Visible-light mediated selective phosphonylation modification of tryptophan residues in oligopeptides

Wenfang Xiong *, Junye He , Jinyao Liu , Peiru Chen , Shiqi Xu , Yipeng Liu , Shiting Chen , Yuanyuan You , Zhenyu Chen * and Jinwu Zhao *
School of Pharmacy, Guangdong Medical University, Dongguan, China. E-mail: xiongwf@gdmu.edu.cn; chenzhy@gdmu.edu.cn; jwzhao@gdmu.edu.cn

Received 7th June 2024 , Accepted 26th July 2024

First published on 1st August 2024


Abstract

Despite their significant importance in biological and medicinal chemistry fields, the difficulties in the site-selective and diverse modification of biomolecules pose substantial obstacles to their applications. Here, we developed a direct C2–H phosphonylation strategy driven by visible light for specific modification of tryptophan containing peptides under exceedingly mild conditions, providing a straightforward and environmentally friendly synthetic method for the preparation of a plethora of phosphorylated tryptophan-containing peptides. Importantly, the protocol is applicable to the late-stage installation of phosphonate motifs into natural peptides, segetalin A and B, and their phosphonylation peptides exhibited better antiproliferative activity against HCT116 and HepG-2 compared with the original segetalins by a CCK-8 assay.


Straightforward late-stage modification of biomolecules, which diversifies biomolecules in an elegant fashion without reliance on a cost- and time-intensive process compared with de novo peptide synthesis, bears enormous potential for chemical biology, proteomics, drug discovery, and pharmaceutical development.1 Thus, the strategies for diversification and functionalization of biomolecules are highly appealing and have received a great deal of attention over the past decades.2 As one of the proteinogenic amino acids, tryptophan (Trp) plays a crucial role in numerous biomolecules and exists in approximately 90% of native proteins despite its low relative abundance. The electron-rich π-system of the indole moiety from tryptophan makes it an excellent target for late-stage modification due to its diverse chemical reactivity. Past decades have witnessed the development of site- and chemoselective functionalization strategies toward the modification of Trp-containing peptides.3 For example, transition metal-catalyzed or metal-free catalyzed direct C2-selective functionalization of the indole ring of Trp or Trp-containing peptides, including arylation,4 fluoridation,5 alkylation,6 alkynylation,7 and so on, have been demonstrated (Scheme 1a). Moreover, photochemical methods have also increasingly been used for the selective modification of tryptophan residues in peptides in recent years by virtue of their distinct advantage to generate radicals in a mild and controlled fashion (Scheme 1b).8 Very recently, Sun and coworkers presented a DMSO/visible light co-mediated chemoselective modification of tryptophan residues in peptides through the construction of the C–S bond at the C2 position of the indole moiety.9 However, although major accomplishments have been achieved, most of the established strategies generally rely on highly active electrophiles and auxiliary directing groups to suppress the competitive reactions of other strongly nucleophilic species or more abundant residues due to their moderate nucleophilicity. Therefore, the development of distinctive chemical bioconjugation methods for the C2-selective functionalization of tryptophan with higher site selectivity and capability remains a necessity but a persistent challenge.
image file: d4qo01028k-s1.tif
Scheme 1 C2-selective functionalization of tryptophan residues in peptides.

Phosphorus plays a pivotal role in regulating a wide range of cellular processes in life, and organophosphorus compounds have been investigated for their widespread occurrence in bioactive natural products, pharmaceuticals, agrochemicals etc. (Scheme 1c).10 In this context, the development of novel approaches for the selective phosphonylation modification of biomolecules is of prime importance. Unfortunately, however, in contrast to innumerable successes in the phosphonylation of simple aromatic heterocyclic compounds,11 the phosphonylation of native Trp-based peptides remains scarce and not commonly used in synthesis due to the underlying difficulty in controlling site-selectivity in native protein peptides containing various residues, including –SH (Cys), –NH2 (Lys) and/or –OH (Tyr). In this work, Trp's inherent photolability is profitably exploited, and a catalytic system driven by visible light that enables a direct C2–H phosphonylation strategy for specific modification of tryptophan-containing peptides under exceedingly mild conditions has therefore been developed, providing a straightforward and environmentally friendly synthetic method for the preparation of a plethora of phosphorylated tryptophan-containing peptides.

We began our studies by investigating the visible-light mediated selective phosphonylation of tryptophan with trimethyl phosphite (2) as the nucleophilic reagent (Table 1). After careful optimization of the reaction conditions, we found that the blue light irradiation of a mixture of methyl acetyl-L-tryptophanate (1) and trimethyl phosphite (2) in the presence of the photocatalyst [Ir(ppy)2(dtbbpy)]PF6 at 450–460 nm in MeCN under air for 18 h at room temperature gave the desired phosphonylation product 3 in 65% isolated yield (Table 1, entry 1). In the absence of light, this reaction could not proceed at all (entry 2). The results of screening wavelengths indicated that lamps operating within the blue light spectrum were all able to promote this phosphonylation transformation, and the optimum yield of the desired product 3 was obtained with the 450–460 nm light source (entries 3 and 4). It was also found that a photocatalyst was essential for this reaction (entry 5). In addition, Ir catalysts showed better activity compared with organic photocatalysts, and PC1 proved to be the optimal catalyst (entries 6–10). Alternative solvents were subsequently investigated, but no improvement was observed compared to the standard conditions (entries 11–16). Finally, we found that this photochemical transformation could not take place if the reaction system was purged with molecular nitrogen, which suggests that air was critical to this phosphonylation reaction (entry 17).

Table 1 Optimization of the reaction conditionsa

image file: d4qo01028k-u1.tif

Entry Deviation from standard conditions Yieldb (%)
a Reactions were performed with 1 (0.2 mmol), 2 (1 mmol), and PC1 (3 mol%) in MeCN (2 mL) under irradiation at 450–460 nm using a 25 W LED lamp at room temperature (cooling by circulating water) for 18 h. b Isolated yield.
1 None 65
2 No light (dark) nr
3 Irradiated with a 420–430 nm lamp 40
4 Irradiated with a 410–420 nm lamp 23
5 No PC 10
6 Catalyzed by PC2 55
7 Catalyzed by PC3 52
8 Catalyzed by PC4 30
9 Catalyzed by PC5 21
10 Catalyzed by PC6 15
11 Replaced MeCN with THF 61
12 Replaced MeCN with DMSO 39
13 Replaced MeCN with CH2Cl2 20
14 Replaced MeCN with isopropyl acetate 59
15 Replaced MeCN with toluene nr
16 Replaced MeCN with H2O nr
17 No air (N2) nr
image file: d4qo01028k-u2.tif


With the optimal conditions established, we first investigated the feasibility of generalizing the visible light-mediated chemoselective phosphonylation modification of tryptophan and tryptophan-containing oligopeptides (Scheme 2). In addition to the model substrate methyl acetyl-L-tryptophanate (1), other protected tryptophans, such as ethyl (tert-butoxycarbonyl)-L-tryptophanate and methyl acetyl-L-tryptophanate, proceeded smoothly, giving the corresponding desired products (4–5) in moderate yields. In particular, unprotected amino acids, such as acetyl-L-tryptophan, (((9H-fluoren-9-yl)methoxy)carbonyl)-L-tryptophan and (tert-butoxycarbonyl)-L-tryptophan, could successfully be modified at the C-2 position of the indole moiety of tryptophan in moderate yields (6–8). Having realized the selective phosphonylation of simple tryptophan derivatives, we further employed a series of tryptophan-containing oligopeptides to evaluate the applicability. Encouragingly, under the standard conditions with phosphite ester as the coupling partner, a number of tryptophan-containing dipeptides that harbour other relatively inert residues such as phenylalanine, leucine, valine, and glutamate, were able to undergo this transformation, giving the corresponding phosphonylation dipeptides efficiently (9–16). It is worth noting that when a tryptophan-containing dipeptide with an electron-rich phenyl ring (S13) was used as the starting material, a trace amount of the phosphorylated side product occurring at the electron-rich arene moiety was observed by LCMS analysis. In addition, this protocol worked well with a variety of tripeptides, allowing for the selective phosphonylation of their tryptophan residues (17 and 18). It should be noted that Trp-containing oligopeptides bearing free –OH, –NH2 and –SH groups, namely those containing unmasked lysine, tyrosine, serine and cysteine, could not deliver the desired products. Of them, Cys-containing peptides resulted in an unknown mixture, presumably due to the oxidation of sulfur atoms under these photoredox conditions.


image file: d4qo01028k-s2.tif
Scheme 2 Tryptophan or oligopeptide (0.2 mmol), phosphite ester (1 mmol), and PC1 (3 mol%) in MeCN (2 mL) under irradiation at 450–460 nm using a 25 W LED lamp at room temperature (cooling by circulating water) for 18 h, isolated yield.

To further probe the reaction generality, we also examined complex peptide substrates (Scheme 3). Endomorphin, an endogenous peptide with potent analgesic activity owing to its remarkable selectivity and high affinity towards the μ-opioid receptor, could be transformed in good isolated yields under the optimized reaction conditions (20). Segetalin A and B, the natural peptides from Vaccaria segetalis, could also sustain phosphonylation modification exclusively at tryptophan residues in moderate isolated yields, ranging from 48 to 51% after purification by HPLC, which underscores the potential of this strategy for the late-stage modification of complex peptides (22–23, 25). Importantly, the obtained phosphonylation derivatives of segetalin were evaluated for their in vitro inhibitory activity toward HCT116 human colon cancer cells and HepG-2 human hepatocellular carcinoma cells, which showed better cell inhibitory activity compared with the original segetalins (see the ESI).


image file: d4qo01028k-s3.tif
Scheme 3 Late-stage functionalization of natural peptides.

To show the synthetic utility of this visible light-mediated chemoselective phosphonylation modification of tryptophan, a scale-up reaction was carried out with methyl acetyl-L-tryptophanate (1, 1 mmol) and trimethyl phosphite (2, 5 equiv.), delivering the desired product 3 in 54% isolated yield (Scheme 4).


image file: d4qo01028k-s4.tif
Scheme 4 Scale-up reaction.

To gain deeper insight into the reaction mechanism, some control experiments were further executed. When radical scavengers, including 2,2,6,6-tetramethylpiperidinooxy (TEMPO), butylated hydroxytoluene (BHT) and 1,1-diphenylethylene (DPE), were added individually to the reaction of methyl acetyl-L-tryptophanate 1 with trimethyl phosphite 2 under the optimal conditions, a trace amount of the target product was observed in each case (Scheme 5A), and the coupling product of the indole radical intermediate from methyl acetyl-L-tryptophanate 1 with TEMPO or BHT was detected by HRMS (see Scheme S5); these results suggest that the reaction might involve a radical intermediate. Cyclic voltammetry experiments showed that the oxidation potential of the excited photocatalyst [Ir(ppy)2(dtbbpy)]PF6 (E1/2 (IrIII*/IrII) = +0.66 V vs. SCE)12 was lower than the oxidation potential of methyl acetyl-L-tryptophanate (1) (E1/2 = +0.68 V vs. Ag/AgCl) or trimethyl phosphite (2) (E1/2 = +0.71 V vs. Ag/AgCl) (see Scheme S9). Accordingly, the reductive quenching pathway could be ruled out. The Stern–Volmer analysis also disclosed that the excited photocatalyst was quenched by oxygen other than acetyl-L-tryptophanate or trimethyl phosphite (see Scheme S6–S8). Given that the energy transfer between the excited photocatalyst and oxygen is usual, singlet-state oxygen quenchers such as 1,4-diazabicyclo[2.2.2]octane (DABCO) and Co(acac)3 were introduced into the standard reaction system, respectively. The results showed that these quenchers could completely quench the phosphonylation reaction. When anthracene 26 was added to this reaction, the trapping product of singlet oxygen was detected (Scheme 5B). Furthermore, tetraphenylporphyrin (TPP), a viable catalyst for singlet oxygen formation, proved to be beneficial for the visible-light mediated selective phosphonylation reaction (Scheme 5C). All of these results referred to the formation of singlet oxygen in the transformation.


image file: d4qo01028k-s5.tif
Scheme 5 Control experiments.

Based on these observations and previous works,11,13 a reasonable pathway is proposed, as shown in Scheme 6. Upon photoexcitation, PC produces an excited state PC*, which then interacts with dioxygen (O2) by energy transfer to furnish singlet oxygen (1O2). Then, singlet oxygen (1O2) abstracts an electron from methyl acetyl-L-tryptophanate to give a superoxide radical and radical cation intermediate I, which is captured by P(OMe)3 to generate intermediate II. The superoxide radical further performs a takeover of an electron from intermediate II to form the transient intermediate III and releases a hydroxyl anion (OH). Finally, the rearrangement of transient intermediate III gives the desired product.


image file: d4qo01028k-s6.tif
Scheme 6 Plausible reaction pathway.

Conclusions

In conclusion, we have developed a facile and mild strategy for the phosphonylation modification of tryptophan-containing peptides under exceedingly mild conditions. This photoinduced site-selective process was applicable to the late-stage modification of complex peptides, such as segetalin A and B, and the obtained phosphorylated peptides exhibited better cell inhibitory activity toward HCT116 human colon cancer cells and HepG-2 human hepatocellular carcinoma cells compared with the original segetalins by a CCK-8 assay.

Author contributions

J. H., S. X., Y. L. and S. C. carried out the optimization and studied the scope of the reaction. J. L., P. C. and Y. Y. conducted the activity work. W. X., J. Z. and Z. C. directed the project. W. X. and J. Z. conceived the project and prepared the manuscript. All authors commented on this manuscript and gave approval to the final version of this manuscript.

Data availability

Electronic supplementary information (ESI) available: Experimental details, NMR spectra, and HRMS data. For the ESI or other electronic format see https://doi.org/xxx.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

The authors thank the Discipline Construction Project of Guangdong Medical University (4SG24256G, 4SG23004G, and 4SG23249G), the Ordinary University Characteristic Innovation Project of Guangdong Province (2022KTSCX047) and the National Natural Science Foundation of China (22001075) for financial support.

References

  1. (a) G. T. Hermanson, Bioconjugate Techniques, Academic Press, London, 2nd edn, 2008 Search PubMed; (b) J. N. deGruyter, L. R. Malins and P. S. Baran, Residue-specific peptide modification: a chemist's guide, Biochemistry, 2017, 56, 3863–3873 CrossRef CAS PubMed; (c) N. Stephanopoulos and M. B. Francis, Choosing an effective protein bioconjugation strategy, Nat. Chem. Biol., 2011, 7, 876–884 CrossRef CAS PubMed.
  2. (a) L. Reguera and D. G. Rivera, Multicomponent reaction toolbox for peptide macrocyclization and stapling, Chem. Rev., 2019, 119, 9836–9860 CrossRef CAS PubMed; (b) E. A. Hoyt, P. M. S. D. Cal, B. L. Oliveira and G. J. L. Bernardes, Contemporary approaches to site-selective protein modification, Nat. Rev. Chem., 2019, 3, 147–171 CrossRef CAS; (c) L. R. Malins, Peptide modification and cyclization via transition-metal catalysis, Curr. Opin. Chem. Biol., 2018, 46, 25–32 CrossRef CAS PubMed; (d) S. Dong, J.-S. Zheng, Y. Li, H. Wang, G. Chen, Y. Chen, G. Fang, J. Guo, C. He, H. Hu, X. Li, Y. Li, Z. Li, M. Pan, S. Tang, C. Tian, P. Wang, B. Wu, C. Wu, J. Zhao and L. Liu, Recent advances in chemical protein synthesis: method developments and biological applications, Sci. China: Chem., 2024, 67, 1060–1096 CrossRef CAS; (e) Y. Liu, J. Zhou and Z. Sun, Direct synthesis of unnatural amino acids and modifications of peptides via LADA strategy, Chin. Chem. Lett., 2024, 35, 108553–108558 CrossRef CAS.
  3. (a) J. J. Hu, P. Y. He and Y. M. Li, Chemical modifications of tryptophan residues in peptides and proteins, J. Pept. Sci., 2021, 27, e3286 CrossRef CAS PubMed; (b) H. Gruß and N. Sewald, Late-stage diversification of tryptophan-derived biomolecules, Chem. – Eur. J., 2020, 26, 5328–5340 CrossRef PubMed; (c) J. Yin, W. Huang, C. Guo, C. Liu, F. Gao and H. Hu, Tryptophan-specific peptide modification through metal-free photoinduced N-H alkylation employing N-aryl glycines, Chin. Chem. Lett., 2024, 35, 109244–109247 CrossRef CAS; (d) X. Xie, P. J. Moon, S. W. M. Crossley, A. J. Bischoff, D. He, G. Li, N. Dao, A. Gonzalez-Valero, A. G. Reeves, J. M. McKenna, S. K. Elledge, J. A. Wells, F. D. Toste and C. J. Chang, Oxidative cyclization reagents reveal tryptophan cation-π inter-actions, Nature, 2024, 627, 680–687 CrossRef CAS PubMed; (e) J. A. C. Delgado, Y.-M. Tian, M. Marcon, B. König and M. W. Paixão, Side-selective solid-phase metallaphotoredox N(in)-arylation of peptides, J. Am. Chem. Soc., 2023, 145, 26452–26462 CrossRef CAS PubMed; (f) J. A. Swain, S. R. Walker, M. B. Calvert and M. A. Brimble, The tryptophan connection: cyclic peptide natural products linked via the tryptophan side chain, Nat. Prod. Rep., 2022, 39, 410–443 RSC.
  4. (a) C. Perez-Rizquez, O. Abian and J. M. Palomo, Site-selective modification of tryptophan and protein tryptophan residues through PdNP bionanohybridcatalysed C-H activation in aqueous media, Chem. Commun., 2019, 55, 12928–12931 RSC; (b) A. Schischko, H. Ren, N. Kaplaneris and L. Ackermann, Bioorthogonal Diversification of peptides through selective Ru-thenium(II)-catalyzed C-H activation, Angew. Chem., Int. Ed., 2017, 56, 1576–1580 CrossRef CAS PubMed; (c) A. J. Reay, L. A. Hammarback, J. T. W. Bray, T. Sheridan, D. Turnbull, A. C. Whitwood and I. J. S. Fairlamb, Mild and regioselective Pd(OAc)2-c atalyzed C-H arylation of tryptophans by [ArN2]X promoted by tosic acid, ACS Catal., 2017, 7, 5174–5179 CrossRef CAS PubMed; (d) T. J. Williams, A. J. Reay, A. C. Whitwood and I. J. S. Fairlamb, A mild and selective Pd-mediated methodology for the synthesis of highly fluorescent 2-arylated tryptophans and tryptophan-containing peptides: a catalytic role for Pd0 nanoparticles?, Chem. Commun., 2014, 50, 3052–3054 RSC.
  5. (a) Y. Pang, J. W. Lee, K. Kubota and H. Ito, Solid-State Radical C-H trifluoromethylation reactions using ball milling and piezoelectric materials, Angew. Chem., Int. Ed., 2020, 59, 22570–22576 CrossRef CAS PubMed; (b) I. Guerrero and A. Correa, Cu-catalyzed site-selective C(sp2)-H radical trifluoromethylation of tryptophan-containing peptides, Org. Lett., 2020, 22, 1754–1759 CrossRef CAS PubMed; (c) M. Imiołek, G. Karunanithy, W.-L. Ng, A. J. Baldwin, V. Gouverneur and B. G. Davis, Selective radical trifluoromethylation of native residues in proteins, J. Am. Chem. Soc., 2018, 140, 1568–1571 CrossRef PubMed.
  6. (a) A. Schischko, N. Kaplaneris, T. Rogge, G. Sirvinskaite, J. Son and L. Ackermann, Late-stage peptide C-H alkylation for bioorthogonal C-H activation featuring solid phase peptide synthesis, Nat. Commun., 2019, 10, 3553–3562 CrossRef PubMed; (b) S. R. Kandukuri, A. Bahamonde, I. Chatterjee, I. D. Jurberg, E. C. Escudero-Adán and P. Melchiorre, X-Ray characterization of an electron donor-acceptor complex that drives the photochemical alkylation of indoles, Angew. Chem., Int. Ed., 2015, 54, 1485–1489 CrossRef CAS PubMed.
  7. (a) Z. Ruan, N. Sauermann, E. Manoni and L. Ackermann, Manganese-catalyzed C-H alkynylation: expedient peptide syn-thesis and modification, Angew. Chem., Int. Ed., 2017, 56, 3172–3176 CrossRef CAS PubMed; (b) M. B. Hansen, F. Hubálek, T. Skrydstrup and T. Hoeg-Jensen, Chemo- and regioselective ethynylation of tryptophan-containing peptides and proteins, Chem. – Eur. J., 2016, 22, 1572–1576 CrossRef CAS PubMed.
  8. (a) B. Laroche, X. Tang, G. Archer, R. Di Sanza and P. Melchiorre, Photochemical chemoselective alkylation of tryptophan-containing peptides, Org. Lett., 2021, 23, 285–289 CrossRef CAS PubMed; (b) J. Reimler and A. Studer, Visible-light mediated tryptophan modification in oligopeptides employing acylsilanes, Chem. – Eur. J., 2021, 27, 15392–15395 CrossRef CAS PubMed; (c) Y. Yu, L.-K. Zhang, A. V. Buevich, G. Li, H. Tang, P. Vachal, S. L. Colletti and Z.-C. Shi, Chemoselective peptide modification via photocatalytic tryptophan β-position conjugation, J. Am. Chem. Soc., 2018, 140, 6797–6800 CrossRef CAS PubMed; (d) C. Li, Z. Zhao and S. Yu, Photoredox-catalyzed C-glycosylation of peptides with glycosyl bromides, Chin. Chem. Lett., 2024, 35, 109128–109132 CrossRef CAS.
  9. G. Bao, P. Wang, J. Li, X. Song, T. Yu, J. Zhang, Y. Li, Z. He, E. Ruiyao, X. Miao, J. Xie, J. Ni, R. Wang and W. Sun, Dimethyl sulfoxide/visible-Light comediated chemoselective C-S bond formation between tryptophans and thiophenols enables site-selective functionalization of peptides, CCS Chem., 2024, 6, 1547–1556 CrossRef CAS.
  10. (a) J. B. Rodriguez and C. Gallo-Rodriguez, The role of the phosphorus atom in drug design, ChemMedChem, 2019, 14, 190–216 CrossRef CAS PubMed; (b) L. G. Costa, Organophosphorus compounds at 80: some old and new issues, Toxicol. Sci., 2018, 162, 24–35 CrossRef CAS PubMed; (c) J.-N. Volle, R. Guillon, F. Bancel, Y.-A. Bekro, J.-L. Pirat and D. Virieux, Phosphono- and phosphinolactones in the life sciences, Adv. Heterocycl. Chem., 2016, 118, 129–193 CrossRef CAS; (d) B. R. Smith, C. M. Eastman and J. T. Njardarson, Beyond C, H, O, and N! analysis of the elemental composition of U.S. FDA approved drug architectures, J. Med. Chem., 2014, 57, 9764–9773 CrossRef CAS PubMed; (e) N. Wardle, S. Bligh and H. Hudson, Organophosphorus chemistry: therapeutic intervention in mechanisms of viral and cellular replication, Curr. Org. Chem., 2005, 9, 1803–1828 CrossRef CAS.
  11. (a) V. J. Roy and S. R. Roy, Light-induced activation of C–X bond via carbonate-assisted anion-π interactions: applications to C–P and C–B bond formation, Org. Lett., 2023, 25, 923–927 CrossRef CAS PubMed; (b) L. Pan, M. M. Deckert, M. V. Cooke, A. R. Bleeke and S. Laulhé, Solvent anions enable photoinduced borylation and phosphonation of aryl halides via EDA complexes, Org. Lett., 2022, 24, 6466–6471 CrossRef CAS PubMed; (c) I. Kim, G. Kang, K. Lee, B. Park, D. Kang, H. Jung, Y.-T. He, M.-H. Baik and S. Hong, Site-selective functionalization of pyridinium derivatives via visible-light-driven photocatalysis with quinolinone, J. Am. Chem. Soc., 2019, 141, 9239–9248 CrossRef CAS PubMed; (d) P. Peng, L. Peng, G. Wang, F. Wang, Y. Luo and A. Lei, Visible light mediated aerobic radical C–H phosphorization toward arylphosphonates, Org. Chem. Front., 2016, 3, 749–752 RSC; (e) L. Niu, J. Liu, H. Yi, S. Wang, X.-A. Liang, A. K. Singh, C.-W. Chiang and A. Lei, Visible-light-induced external oxidant-free oxidative phosphonylation of C(sp2)–H bonds, ACS Catal., 2017, 7, 7412–7416 CrossRef CAS.
  12. N. Holmberg-Douglas and D. A. Nicewicz, Photoredox-Catalyzed C–H Functionalization Reactions, Chem. Rev., 2022, 122, 1925–2016 CrossRef CAS PubMed.
  13. N. F. Nikitas, D. I. Tzaras, I. Triandafillidi and C. G. Kokotos, Photochemical oxidation of benzylic primary and secondary alcohols utilizing air as the oxidant, Green Chem., 2020, 22, 471–477 RSC.

Footnote

Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d4qo01028k

This journal is © the Partner Organisations 2024
Click here to see how this site uses Cookies. View our privacy policy here.